2013 Conference - Buffalo

Neuroendocrine Tumor Regional Conference

“Multidisciplinary Management of NET Cancers”
Buffalo, New York
June 29, 2013

This forum is designed for physicians and other health professionals from a variety of settings and levels to include the specialties of oncology, endocrinology, surgery, pathology, internal medicine, gastroenterology, nuclear medicine, nursing, nutrition, diagnostic radiology, interventional radiology, and primary care. Leading experts in the field will discuss, through lectures and panel discussions, the different aspects of diagnosis, histopathology, surgery, hepatic directed therapy, and various systemic treatments targeted to specific NET origins. There will be several opportunities for audience questions and networking with faculty.

ACCREDITATION: This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Roswell Park Cancer Institute and the North American Neuroendocrine Tumor Society. Roswell Park Cancer Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

CREDIT DESIGNATIONRoswell Park Cancer Institute designates this live educational activity for a maximum of 7.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

EDUCATIONAL OBJECTIVES: At the conclusion of this educational program, participants should be able to:

  • Utilize the proper assays & diagnostic techniques for identifying and monitoring NET diseases;
  • Incorporate an appropriate sequence for surgical/radiological intervention into the patient’s treatment plan;
  • Interpret diagnostic information and histopathology reports to establish the appropriate treatment modality for the patient;
  • Compare the clinical effectiveness of the different targeted therapies and radiotherapeutic approaches to assess which intervention would be most appropriate for patients with different neuroendocrine tumors;
  • Formulate a multidisciplinary system to improve the quality of care for NET patients.

DISCLOSURE STATEMENT:  All planners, speakers, authors, reviewers and staff members involved with content development for continuing education activities sponsored by Roswell Park Cancer Institute are expected to disclose any real or perceived conflict of interest related to the content of the activity. Detailed disclosures will be included in participant materials or given prior to the start of the activity.  


Attendees are responsible for all airfare, lodging, and transportation costs. The program fee includes: Catered break, breakfast and lunch and all instructional materials. To ensure enrollment, register and pay online or complete the registration form online, print and mail it with your tuition payment as soon as possible. To help meet administrative costs, a service charge of $25 will be assessed on all refund requests received by June 19, 2013. No refunds can be issued after that date. Should conditions warrant, the sponsors reserve the right to cancel this program with a full tuition refund. Please register early as enrollment will be limited.  If you require special assistance, please contact Kari @ 360.314.4112.


PHYSICIANS/PhD (MD, MD/PhD, PhD, DO, Pharmacy, DVM) - $50.00

Other Medical Professionals (PA, NP, RN, RD, FNP, LSCW) -  $25.00

Others Professionals 
(industry, pharmacy representatives,  allied members) - $25.00

Residents, Fellows, Students 
- $0.00



Saturday – June 29, 2013


 7:30 am –   8:15 am

Registration & Breakfast

 8:15 am –   8:20 am

Welcome & Introductions – Renuka Iyer

 8:20 am –   10:15 am

Presentation and Diagnosis  - Renuka Iyer, Charles LeVea, Andrew Bain, Ajay Chaudhari, Eric Liu

  • Overview of Carcinoid Tumors and Other NETs –

    • General Background & Epidemiology -  Renuka Iyer

    • Biomarkers: Interpreting Laboratory Results to Clinical Use - Renuka Iyer

    • Familial NETs -  Ajay Chaudhari

  • Pathology – Charles LeVea

    • General Features

    • Organ Specific Issues

    • Grading, Staging and Classification

    • Minimum Pathology data set

  • Diagnosis of NETs

    • Endoscopy & Colonoscopy – Andrew Bain

    • Radiological Imaging – Selecting the Right Procedure & Contrast Agents- Eric Liu

    • Nuclear Imaging - Which Techniques are Most Efficient for Localizing Tumors? - Eric Liu

    • Obstacles In Diagnosis For the Clinician – Eric Liu

    • Q & A

10:15 am – 10:30 am


10:30 am – 12:00 pm

Surgical Options: Making the Right Choice – Steven Hochwald, Boris Kuvshinoff, Thomas Clancy

  • Surgical Intervention of NETs

    • Surgery for Pancreatic Endocrine Tumors – Steven Hochwald

    • Surgery for Stomach, Small Bowel, Appendiceal and Rectal NETs – Thomas Clancy

    • Removal of Primary & Mesenteric Nodal Mass –Thomas Clancy

    • Resection of Liver Mets & Laparoscopy – Boris Kuvshinoff  

    • Q & A

12:00 pm – 12:30 pm

The Role of Interventional Radiology in the Diagnosis & Management of NETs  - Bulent Arslan

  • Diagnosis of NETs

    • Image guided biopsy

    • CT/Ultrasound/MRI guided treatment

  • Management of Hepatic Metastases

    • Embolotherapy & Ablation

    • Q & A

12:30 pm –  1:30 pm


 1:30 pm – 2:30 pm

Management of Hormonal Syndromes from NETs – Neal Wilkinson, William Cance, Marc Shapiro

  • Functioning & Non Functioning Pancreatic NETs – Neal Wilkinson

  • Hereditary Syndromes and Management of Medullary Thyroid Carcinoma – William Cance

  • Carcinoid Syndrome – Marc Shapiro

    • Symptomatic Control (octreotide, lanreotide, pasireotide,telotristat etiprate)

    • Disease Stabilization and Improved Survival (PROMID study)

    • Managing Persistent/Recurrent Diarrhea

    • Carcinoid Heart Disease

    • Q & A

 2:30 pm –  3:50 pm  

Medical Management of NETs –  Jianliang Zhang, Renuka Iyer, George Fisher ,Eric Liu

  • Evolving Molecular Targets in NETs - Jianliang Zhang

  • Systemic Therapies

    • Overview Cytotoxic Therapies – Renuka Iyer  

    • Clinical Development of VEGF Pathway  & mTOR Inhibitors in NETs-  George Fisher

    • Peptide Receptor Radionuclide Therapy –Current Status in US - Eric Liu

    • Other Current Clinical Trials – Eric Liu

    • Q & A

3:50 pm –  4:30 pm  

Developing a Multidisciplinary  Team & Case Presentations – George Fisher & Panel

  • Q & A

Please do not include credentials.
Login or Register to receive member benefits

Location of Conference:   Buffalo Marriott Niagara * 1340 Millersport Highway * Amherst, NY  

Hotel for Accomodations: Courtyard Buffalo Marriott *4243 Genesee Street* Cheektowaga, NY  Group Rate is $129.
For Hotel Reservations/Accomodations:   Courtyard Buffalo Airport  or  Call: 716.633.2700 or 1.888.793.9359 (use group code – NETNETA)